Business Context and Reporting Period
This Form 6-K filing by Raytech Holding Ltd covers the month of January 2026, with the report dated January 7, 2026. The filing primarily addresses corporate governance changes, specifically the resignation of two directors and the subsequent appointment of two new directors to the Board.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding board composition and does not contain financial performance data.
Material Changes
- Resignations: Chun Yin Ling and Wan Venus Li resigned from the Board effective January 2, 2026. Ms. Li also stepped down from the Audit Committee, Compensation Committee, and her role as Chairperson of the Nominating and Corporate Governance Committee.
- Appointments: Tianfu Yuan was appointed as a director to fill Mr. Ling's vacancy. Shibin Wang was appointed as an independent director to fill Ms. Li's vacancy.
- Committee Roles: Dr. Wang assumed the roles of member of the Audit Committee and Compensation Committee, and Chairperson of the Nominating and Corporate Governance Committee.
- Compensation: Dr. Wang is entitled to an annual cash compensation of $14,400, payable quarterly. Mr. Yuan will not receive any compensation.
Outlook, Risks, and Management Commentary
Management stated that the resignations were not the result of any disagreement with the Company or the Board, and the departing directors have no claims against the Company. The Company confirmed that Dr. Wang qualifies as an independent director under Nasdaq Listing Rules and SEC regulations. The filing incorporates by reference the Company's registration statement on Form F-3 (Registration No. 333-290696), which was declared effective on December 18, 2025.
Key Facts for Investor Verification
- Verify the independence status of Dr. Shibin Wang under current Nasdaq rules.
- Review the biographical backgrounds of new directors Tianfu Yuan and Shibin Wang for potential conflicts of interest.
- Confirm the status of the Form F-3 registration statement (No. 333-290696) referenced in the filing.
- Check for any subsequent filings regarding the Company's financial performance, as this 6-K contains no financial data.